<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To determine the prevalence of the hyperdense middle cerebral artery sign (HMCAS) in an <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> population (treated with intravenous tissue plasminogen activator (tPA) within 90 minutes of <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo>); to correlate the presence/absence of the sign with arteriographic findings; and to correlate the HMCAS with the volume of subsequent infarction </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: 55 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> underwent CT to exclude <z:hpo ids='HP_0001342'>cerebral hemorrhage</z:hpo> and were then treated with intravenous tPA </plain></SENT>
<SENT sid="2" pm="."><plain>The neuroradiologist, blinded to the clinical and arteriographic data, sought the HMCAS on the initial and subsequent scans </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The HMCAS was detected by CT in 19 of 55 (34.5%) patients (one false positive) </plain></SENT>
<SENT sid="4" pm="."><plain>Arteriograms in 14 of the 18 true positive patients confirmed the CT-predicted middle cerebral artery segment in 12 </plain></SENT>
<SENT sid="5" pm="."><plain>The 18 patients developed <z:mpath ids='MPATH_124'>infarcts</z:mpath> larger than patients not exhibiting the sign (132 cc vs 52 cc, P less than .002) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: The HMCAS does predict middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> and subsequent development of a large <z:mpath ids='MPATH_124'>infarct</z:mpath> </plain></SENT>
</text></document>